Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	147,123	147,123	129,645	126,676	115,993	106,342
Revenue Growth	13.48%	13.48%	2.34%	9.21%	9.07%	19.96%
Gross Profit Gross Profit Growth	96,195	96,195	80,391	76,034	65,785	63,536
Operating Income Operating Income Growth	26,232	26,232	21,518	19,676	13,196	17,432
Net Income Net Income Growth	23,018	23,018	21,655	17,958	9,842	16,456
Earnings Per Share EPS Growth	192.51	192.51	181.11	150.19	82.31	137.63
EPS Growth	6.29%	6.29%	20.59%	82.47%	-40.20%	3.82%

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	98,514	98,514	91,436	86,620	81,600	75,266
Other International Other International Growth	16,964	16,964	13,392	12,346	9,259	7,785
United States (US) United States (US) Growth	29,845	29,845	24,818	27,709	25,134	23,291
Total Total Growth	145,323	145,323	129,645	126,676	115,993	106,342

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	49,927	49,927	41,047	42,697	11,432	13,130
Total Debt Total Debt Growth	20,472	20,472	13,809	14,184	13,967	26,682
Net Cash (Debt) Net Cash Growth	29,456	29,456	27,238	28,513	-2,535	-13,552
Net Cash Growth	8.14%	8.14%	-4.47%	-	-	-
Net Cash Per Share Net Cash Per Share Growth	246.35	246.35	227.81	238.47	-21.20	-113.34

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	19,630	19,630	19,128	19,481	16,825	11,110
Capital Expenditures CapEx Growth	-6,173	-6,173	-6,756	-2,593	-2,329	-3,389
Free Cash Flow Free Cash Flow Growth	13,458	13,458	12,372	16,888	14,496	7,721
Free Cash Flow Growth	8.77%	8.77%	-26.74%	16.50%	87.74%	-27.84%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	65.38%	65.38%	62.01%	60.02%	56.72%	59.75%
Operating Margin	17.83%	17.83%	16.60%	15.53%	11.38%	16.39%
Pretax Margin	19.50%	19.50%	19.49%	15.97%	11.25%	17.34%
Profit Margin	15.65%	15.65%	16.70%	14.18%	8.48%	15.47%
FCF Margin	9.15%	9.15%	9.54%	13.33%	12.50%	7.26%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 26, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	53.000	53.000	45.000	40.000	25.000	34.000
Dividend Per Share Growth	17.78%	17.78%	12.50%	60.00%	-26.47%	13.33%
Dividend Yield	0.94%	1.00%	0.93%	0.82%	0.76%	0.98%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 26, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	29.26	27.53	26.95	32.91	41.26	26.31
Forward PE	28.63	27.02	24.55	28.26	26.11	23.64
P/FCF Ratio	50.04	47.08	47.18	34.99	28.01	56.07
PS Ratio	4.58	4.31	4.50	4.67	3.50	4.07

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error